Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-19-053327

EVP & Chief Tech Ops Officer acquired 1,434 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Huang Dennis Karl · EVP & Chief Tech Ops Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-10-14 Grant or award : show line 1 in the form +1,434 23,579 D
Loading xslF345X03/doc4.xml…